| A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii B Luna, V Trebosc, B Lee, M Bakowski, A Ulhaq, J Yan, P Lu, J Cheng, ... Nature microbiology 5 (9), 1134-1143, 2020 | 55 | 2020 |
| Horizontal gene transfer of antibiotic resistance from Acinetobacter baylyi to Escherichia coli on lettuce and subsequent antibiotic resistance transmission to the gut microbiome M Maeusli, B Lee, S Miller, Z Reyna, P Lu, J Yan, A Ulhaq, N Skandalis, ... MSphere 5 (3), 10.1128/msphere. 00329-20, 2020 | 52 | 2020 |
| Natural history of Acinetobacter baumannii infection in mice BM Luna, J Yan, Z Reyna, E Moon, TB Nielsen, H Reza, P Lu, R Bonomo, ... PloS one 14 (7), e0219824, 2019 | 32 | 2019 |
| Monoclonal Antibody Therapy against Acinetobacter baumannii TB Nielsen, J Yan, M Slarve, P Lu, R Li, J Ruiz, B Lee, E Burk, ... Infection and Immunity 89 (10), 2021 | 27 | 2021 |
| Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii J Cheng, J Yan, Z Reyna, M Slarve, P Lu, B Spellberg, B Luna Antimicrobial Agents and Chemotherapy 65 (4), 10.1128/aac. 02204-20, 2021 | 21 | 2021 |
| A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens J Yan, TB Nielsen, P Lu, Y Talyansky, M Slarve, H Reza, B Novakovic, ... Science translational medicine 15 (716), eadf9556, 2023 | 13 | 2023 |
| In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas … B Lee, J Yan, A Ulhaq, S Miller, W Seo, P Lu, R She, B Spellberg, B Luna Msphere 6 (6), e00920-21, 2021 | 10 | 2021 |
| Horizontal gene transfer of antibiotic resistance from Acinetobacter baylyi to Escherichia coli on lettuce and subsequent antibiotic resistance transmission to the gut … M Maeusli, B Lee, S Miller, Z Reyna, P Lu, J Yan, A Ulhaq, N Skandalis, ... | 8 | 2020 |
| Individual components of polymyxin B modeled via population pharmacokinetics to design humanized dosage regimens for a bloodstream and lung infection model in immune-competent mice Y Jiao, J Yan, M Vicchiarelli, DS Sutaria, P Lu, Z Reyna, B Spellberg, ... Antimicrobial Agents and Chemotherapy 67 (5), e00197-23, 2023 | 3 | 2023 |
| Acacia fiber protects the gut from extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli colonization enabled by antibiotics M Maeusli, N Skandalis, B Lee, P Lu, S Miller, J Yan, Y Talyansky, R Li, ... Msphere 7 (3), e00071-22, 2022 | 3 | 2022 |
| Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream … Y Jiao, J Yan, DS Sutaria, P Lu, M Vicchiarelli, Z Reyna, J Ruiz-Delgado, ... Antimicrobial Agents and Chemotherapy 68 (3), e01394-23, 2024 | | 2024 |
| Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae … P Lu, F Alletto, B Lee, E Burk, J Martinez, F Prati, E Caselli, B Spellberg, ... Plos one 18 (6), e0287102, 2023 | | 2023 |
